Correlation Between Vaxcyte and Dyne Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vaxcyte and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxcyte and Dyne Therapeutics, you can compare the effects of market volatilities on Vaxcyte and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and Dyne Therapeutics.

Diversification Opportunities for Vaxcyte and Dyne Therapeutics

VaxcyteDyneDiversified AwayVaxcyteDyneDiversified Away100%
0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Vaxcyte and Dyne is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of Vaxcyte i.e., Vaxcyte and Dyne Therapeutics go up and down completely randomly.

Pair Corralation between Vaxcyte and Dyne Therapeutics

Given the investment horizon of 90 days Vaxcyte is expected to generate 0.6 times more return on investment than Dyne Therapeutics. However, Vaxcyte is 1.66 times less risky than Dyne Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Dyne Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  3,788  in Vaxcyte on December 12, 2024 and sell it today you would earn a total of  3,197  from holding Vaxcyte or generate 84.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vaxcyte  vs.  Dyne Therapeutics

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -50-40-30-20-100
JavaScript chart by amCharts 3.21.15PCVX DYN
       Timeline  
Vaxcyte 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar7075808590
Dyne Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar152025

Vaxcyte and Dyne Therapeutics Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-5.33-3.99-2.65-1.320.01.172.353.544.73 0.0150.0200.0250.0300.0350.040
JavaScript chart by amCharts 3.21.15PCVX DYN
       Returns  

Pair Trading with Vaxcyte and Dyne Therapeutics

The main advantage of trading using opposite Vaxcyte and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.
The idea behind Vaxcyte and Dyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Directory
Find actively traded commodities issued by global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.